Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilioinguinal Block vs Local Infiltration for TF-TAVI
NCT05220813Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Nov 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in procedural pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Conversion to General Anesthesia. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT05220813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05220813.